Myfortic
Showing 1 - 25 of 169
Myfortic (Mycophenolate Sodium) in Patients With Lupus Nephritis
Recruiting
- Lupus Nephritis
- Myfortic
-
Kaohsiung City, Taiwan
- +3 more
Aug 12, 2022
Type 1 Diabetes Trial in Miami (Myfortic)
Recruiting
- Type 1 Diabetes Mellitus
- Myfortic
-
Miami, FloridaDiabetes Research Institute
Mar 1, 2022
Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)
Active, not recruiting
- Lymphoma, Non-Hodgkin
- Stem cell infusion
- +5 more
-
Saint Louis, MissouriWashington University
Jan 17, 2023
Liver Transplantation Trial in Los Angeles (Basiliximab, Tacrolimus, Mycophenolic Acid)
Completed
- Liver Transplantation
- Basiliximab
- +2 more
-
Los Angeles, CaliforniaRonald Reagan UCLA Medical Center
Sep 14, 2022
Acute Myeloid Leukemia Trial in Saint Louis (Graft cell infusion, Tacrolimus, Mycophenolate mofetil)
Recruiting
- Acute Myeloid Leukemia
- Graft cell infusion
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 29, 2023
Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit
Recruiting
- Sickle Cell Disease
- +4 more
- Cyclophosphamide
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 6, 2022
Diabetes, Immunosuppression Trial in Galveston (Gastric emptying test)
Terminated
- Diabetes
- Immunosuppression
- Gastric emptying test
-
Galveston, TexasUniversity of Texas Medical Branch
Nov 12, 2020
Gastrointestinal Symptoms, Heart Transplantation Trial in Los Angeles (Mycophenolate Sodium)
Completed
- Gastrointestinal Symptoms
- Heart Transplantation
- Mycophenolate Sodium
-
Los Angeles, CaliforniaCedars- Sinai Medical Center
Jul 20, 2020
Carcinoma, Hepatocellular Trial in United States (Everolimus, Tacrolimus, Myfortic)
Active, not recruiting
- Carcinoma, Hepatocellular
- Everolimus
- +4 more
-
San Francisco, California
- +8 more
Jul 19, 2022
Renal Transplantation Trial in San Francisco (sirolimus)
Completed
- Renal Transplantation
-
San Francisco, CaliforniaCalifornia Pacific Medical Center; Barry S. Levin, MD Department
Oct 2, 2020
Lung Transplant Rejection, Antibody-mediated Rejection Trial in Saint Louis, Houston (Belatacept, Tacrolimus, ATG)
Active, not recruiting
- Lung Transplant Rejection
- Antibody-mediated Rejection
- Belatacept
- +5 more
-
Saint Louis, Missouri
- +1 more
Nov 2, 2021
End-Stage Renal Disease Trial in Vancouver (Conversion to Advagraf, conversion of non-immunosuppressant drugs to once daily,
Active, not recruiting
- End-Stage Renal Disease
- Conversion to Advagraf
- +2 more
-
Vancouver, British Columbia, Canada
- +2 more
Oct 5, 2021
Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant Trial in United States (biological, drug,
Recruiting
- Kidney Transplant
- +3 more
- Polyclonal Regulatory T Cells
- +10 more
-
Birmingham, Alabama
- +5 more
Feb 22, 2022
Immunosuppression, Renal Failure Trial in Hershey (Arm A: Everolimus, Calcineurin Inhibitor)
Completed
- Immunosuppression
- Renal Failure
- Arm A: Everolimus
- Calcineurin Inhibitor
-
Hershey, PennsylvaniaPenn State College of Medicine; Penn State Milton S Hershey Medi
Jan 12, 2021
Disorder Related to Renal Transplantation, Effects of Immunosuppressant Therapy Trial in Worldwide (Tacrolimus (for Group B),
Completed
- Disorder Related to Renal Transplantation
- Effects of Immunosuppressant Therapy
- Tacrolimus (for Group B)
- +5 more
-
Prague, Prague 4, Czechia
- +7 more
Jan 28, 2021
GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)
Recruiting
- GVHD
- +15 more
- FLUDARABINE
- +6 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 30, 2021
Renal Transplantation Trial in United States (Alemtuzumab, rabbit antithymocyte globulin, Belatacept)
Kidney Transplantation Trial in Buffalo (Kidney Biopsy, Rapamune (sirolimus/rapamycin), Tacrolimus)
Completed
- Kidney Transplantation
- Kidney Biopsy
- +2 more
-
Buffalo, New YorkBuffalo General Hospital Multi-Organ Transplant Department
Nov 4, 2020
Implant or Graft; Rejection Trial in New York (Belatacept, Tacrolimus, Mycophenolate)
Completed
- Implant or Graft; Rejection
- Belatacept
- +5 more
-
New York, New YorkColumbia University Medical Center
Jan 26, 2021
High Probability of Poorly Responding to Therapy With
Completed
- Renal Transplantation
- MPA SNP
-
Vienna, AustriaDepartment of Medicine III, Division of Nephrology
Sep 9, 2020
Kidney Transplant Rejection, Gastrointestinal Disorder, Functional Trial in Saint Louis (Everolimus, Mycophenolic Acid)
Terminated
- Kidney Transplant Rejection
- Gastrointestinal Disorder, Functional
- Everolimus
- Mycophenolic Acid
-
Saint Louis, MissouriWashington University
Aug 7, 2020
High Model for End-Stage Liver Disease (MELD) Score Trial in Aurora (Everolimus, Myfortic and Tacrolimus, Myfortic and
Withdrawn
- High Model for End-Stage Liver Disease (MELD) Score
- Everolimus, Myfortic and Tacrolimus
- Myfortic and Tacrolimus
-
Aurora, ColoradoUniversity of Colorado Denver
Oct 17, 2019
Liver Transplantation Trial in San Francisco, Chicago, Rochester (biological, drug, procedure)
Terminated
- Liver Transplantation
- Anti-Thymocyte Globulin - Rabbit
- +12 more
-
San Francisco, California
- +2 more
Sep 2, 2020
Kidney Transplantation, Pancreas Transplantation, Diabetes Trial in Nantes (Tacrolimus and Tacrolimus Extended Release Oral
Recruiting
- Kidney Transplantation
- +2 more
- Tacrolimus and Tacrolimus Extended Release Oral Tablet [Envarsus]
-
Nantes, FranceNantes University Hospital
Aug 10, 2022